← Leaderboards
Ernesto Guccione
Icahn School Of Medicine At Mount Sinai
$11,143,318
Attributed
$14,053,774
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2020–25$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,053,774 · 11
By mechanism
R01$11,853,803 · 5
P30$1,212,032 · 3
UH3$700,716 · 1
UH2$280,223 · 1
R13$7,000 · 1
Top collaborators
- Arvin Dar6 shared
- Amaia Lujambio6 shared
- Jordi Ochando3 shared
- Samir Parekh3 shared
- Ivan Marazzi1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- James J Bieker$21,475,352
- Samir Parekh$6,034,549
- Jordi Ochando$5,634,948
- Lucas Ferrari De Andrade$1,481,935
- Jianlong Wang$10,059,386
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsChromatinGeneticGenesProteinsSignal TransductionGenetic TranscriptionPhenotypeMediatingPathway InteractionsProgramsFutureMalignant NeoplasmsMemberEventOncogenicIn VivoAntisense OligonucleotidesMutationFamilyGene ExpressionPharmaceutical PreparationsBindingEmbryonic Development
Grant awards (36)
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS$630,404
R01 · FY2025 · CA · contact PI
DISSECTING THE ROLE OF PRDM15 IN NORMAL HEMATOPOIESIS AND B-CELL MALIGNANCIES$490,068
R01 · FY2025 · CA · contact PI
FUNCTIONAL CHARACTERIZATION OF THE PRDM10-ZN FINGER TRANSCRIPTION FACTOR IN EARLY MAMMALIAN DEVELOPMENT$363,350
R01 · FY2025 · HD · contact PI
FUNCTIONAL CHARACTERIZATION OF NOVEL DETERMINANTS OF HOLOPROSENCEPHALY (HPE)$363,350
R01 · FY2025 · HD · contact PI
Implementation of a qPCR-based assay for the quantification of SARS-CoV-2-specific T cells in immunocompromised patients$350,358
UH3 · FY2025 · CA · contact PI
Resource Core D - Bioinformatics and Statistical Analysis Core$194,754
P30 · FY2025 · AR · contact PI
Bioinformatics for Next Generation Sequencing$151,489
P30 · FY2025 · CA · contact PI
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS$598,885
R01 · FY2024 · CA · contact PI
DISSECTING THE ROLE OF PRDM15 IN NORMAL HEMATOPOIESIS AND B-CELL MALIGNANCIES$465,562
R01 · FY2024 · CA · contact PI
Therapeutic targeting of RNA splicing catalysis through inhibition of Protein Arginine Methylation$364,398
R01 · FY2024 · CA · contact PI
FUNCTIONAL CHARACTERIZATION OF THE PRDM10-ZN FINGER TRANSCRIPTION FACTOR IN EARLY MAMMALIAN DEVELOPMENT$359,717
R01 · FY2024 · HD · contact PI
FUNCTIONAL CHARACTERIZATION OF NOVEL DETERMINANTS OF HOLOPROSENCEPHALY (HPE)$359,717
R01 · FY2024 · HD · contact PI
Implementation of a qPCR-based assay for the quantification of SARS-CoV-2-specific T cells in immunocompromised patients$350,358
UH3 · FY2024 · CA · contact PI
Resource Core D - Bioinformatics and Statistical Analysis Core$216,394
P30 · FY2024 · AR · contact PI
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS$617,796
R01 · FY2023 · CA · contact PI
DISSECTING THE ROLE OF PRDM15 IN NORMAL HEMATOPOIESIS AND B-CELL MALIGNANCIES$480,257
R01 · FY2023 · CA · contact PI
Therapeutic targeting of RNA splicing catalysis through inhibition of Protein Arginine Methylation$375,903
R01 · FY2023 · CA · contact PI
FUNCTIONAL CHARACTERIZATION OF NOVEL DETERMINANTS OF HOLOPROSENCEPHALY (HPE)$363,350
R01 · FY2023 · HD · contact PI
FUNCTIONAL CHARACTERIZATION OF THE PRDM10-ZN FINGER TRANSCRIPTION FACTOR IN EARLY MAMMALIAN DEVELOPMENT$363,350
R01 · FY2023 · HD · contact PI
Implementation of a qPCR-based assay for the quantification of SARS-CoV-2-specific T cells in immunocompromised patients$280,223
UH2 · FY2023 · CA · contact PI
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS$253,500
R01 · FY2023 · CA · contact PI
Resource Core D - Bioinformatics and Statistical Analysis Core$216,394
P30 · FY2023 · AR · contact PI
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS$617,796
R01 · FY2022 · CA · contact PI
DISSECTING THE ROLE OF PRDM15 IN NORMAL HEMATOPOIESIS AND B-CELL MALIGNANCIES$480,370
R01 · FY2022 · CA · contact PI
Therapeutic targeting of RNA splicing catalysis through inhibition of Protein Arginine Methylation$383,572
R01 · FY2022 · CA · contact PI
FUNCTIONAL CHARACTERIZATION OF THE PRDM10-ZN FINGER TRANSCRIPTION FACTOR IN EARLY MAMMALIAN DEVELOPMENT$363,350
R01 · FY2022 · HD · contact PI
FUNCTIONAL CHARACTERIZATION OF NOVEL DETERMINANTS OF HOLOPROSENCEPHALY (HPE)$363,350
R01 · FY2022 · HD · contact PI
Resource Core D - Bioinformatics and Statistical Analysis Core$216,394
P30 · FY2022 · AR · contact PI
FASEB SRC: The Biological Methylation Conference: Fundamental Mechanism in Human Health and Disease$7,000
R13 · FY2022 · CA · contact PI
Therapeutic targeting of RNA splicing catalysis through inhibition of Protein Arginine Methylation$663,748
R01 · FY2021 · CA · contact PI
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS$631,336
R01 · FY2021 · CA
DISSECTING THE ROLE OF PRDM15 IN NORMAL HEMATOPOIESIS AND B-CELL MALIGNANCIES$491,507
R01 · FY2021 · CA · contact PI
FUNCTIONAL CHARACTERIZATION OF NOVEL DETERMINANTS OF HOLOPROSENCEPHALY (HPE)$364,246
R01 · FY2021 · HD · contact PI
FUNCTIONAL CHARACTERIZATION OF THE PRDM10-ZN FINGER TRANSCRIPTION FACTOR IN EARLY MAMMALIAN DEVELOPMENT$363,798
R01 · FY2021 · HD · contact PI
Resource Core D - Bioinformatics and Statistical Analysis Core$216,607
P30 · FY2021 · AR · contact PI
Therapeutic targeting of RNA splicing catalysis through inhibition of Protein Arginine Methylation$681,123
R01 · FY2020 · CA · contact PI